A single-centre retrospective cohort study on outcomes of Covid19. [COVID-19]
Research type
Research Study
Full title
Outcomes of Covid19: The effect of high dose thromboprophylaxis and laboratory values on thrombosis and mortality rates.
IRAS ID
284680
Contact name
Heidi Chandler
Contact email
Sponsor organisation
NHS Barking, Havering and Redbridge NHS Trust
Duration of Study in the UK
0 years, 3 months, 1 days
Research summary
The Coronavirus pandemic has taken its toll worldwide causing over 33000 deaths in the UK as of the 15th of April 2020. One of the main challenges the medical community had to face was dealing with the unknown with regards to who is more likely to become seriously ill or die of the Covid19 disease. \n\nThis is a retrospective study on the basic demographics, laboratory values, administration of prophylactic anticoagulation during hospital admission, rate of thromboembolic events, arterial thrombotic events and mortality in a subset of patients admitted to Queen’s hospital. This subset are patients who were diagnosed with Covid19 either clinically or by positive throat swab who were inpatients in one of the intensive care beds of Barking, Havering and Redbridge NHS Trust hospitals (Queen’s hospital, Romford and King George Hospital, Ilford) during the period of 1st to 30th of April 2020. \n\nThe data will be collected by a team of eleven junior doctors and a Consultant Haematologist employed by Barking, Havering and Redbridge NHS Trust who are also part of team of doctors working in the Trust and caring for the patients during the current Covid pandemic.\n\nThe retrospective data collection will occur in the premises of the Trust using the available information for these patients from their electronic of paper hospital clinical records which can be accessed by all members of the research team as part of their clinical work. The data analysis and processing will occur by the same team of clinicians following anonymisation and coding of the patients’ identifiable details. All data relating to demographic values will be published in the form of describing the population as a whole (for example average values and total number of patients with an existing comorbidity or thromboembolic event) in order to avoid possible identification of individual patients. \n
REC name
N/A
REC reference
N/A